癌症的侵袭和转移:分子洞察力和治疗点
Yongxing Li1,2, Fengshuo Liu3,4,5,6,7, Qingjin Cai1,2
1Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Signal transduction and targeted therapy
|February 20, 2025
概括
瘤转移会导致二次瘤,影响患者的生存. 这项研究研究了转移机制和治疗策略,重点关注器官热带症和新兴治疗方法,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 翻译医学是一种翻译医学.
背景情况:
- 恶性瘤的进展往往导致骨,大脑,肝脏和肺部等器官的二次瘤.
- 瘤转移显著恶化了患者的预后,生活质量和生存率.
- 当前的研究往往侧重于特定的癌症类型,在了解转移级联和器官热带性方面留下了空白.
研究的目的:
- 检查瘤转移的顺序过程.
- 阐明驱动器官热带转移的机制.
- 系统地分析转移性瘤的治疗策略,包括器官特异性治疗和新兴技术.
主要方法:
- 关于瘤转移的现有文献的审查和综合.
- 对器官特异性转移背后的生物学机制的分析.
- 对转移性癌症的现有和新兴治疗策略的评估.
- 检查骨转移的临床研究中的挑战和机遇.
主要成果:
- 详细检查瘤转移的连续步骤.
- 解释负责器官特异性转移 (热) 的关键机制.
- 对治疗干预措施的系统分析,包括对转移性瘤的新方法.
- 识别骨转移研究中的挑战和未来方向.
结论:
- 对转移机制的全面理解对于改善患者的治疗结果至关重要.
- 针对性疗法和新兴技术对治疗转移性疾病充满希望.
- 需要进一步的研究,特别是关于器官热带和骨转移,以推进临床实践.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


